Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Strong feelings – latest findings on pain sensitivity

29.08.2006
The recent discovery of the amplification of even low levels of pain has prompted the organisation of an upcoming symposium in Vienna on "Risk Assessment in Pain Therapy". This international expert meeting will aim to optimise pain therapy by taking account of this previously unknown phenomenon. As a result the findings of an Austrian Science Fund FWF project, which were recently published in SCIENCE, may soon be benefiting patients who suffering severe chronic pain.

Constant pain can really get on your nerves – literally! The phenomenon of pain sensitivity enhancement is responsible for this. In the case of persistent pain impulses, it brings about permanent changes in the neurons responsible for transmitting the pain signals. This leads to an increase in pain sensitivity and the sensation of pain can even persist long after the actual pain signals has faded out.

Strong and Weak

Pain sensitivity enhancement is a feature of both weak and strong pain, but the model used to explain how this phenomenon arises is based solely on the testing of strong pain impulses. In reality, though, low level pain does not give rise to all of the neural processes which are postulated by the previous explanatory model.

Now, a team under Prof. Jürgen Sandkühler of the Department of Neurophysiology at the Medical University of Vienna has published findings in the June 2006 edition of SCIENCE which explain the existence of pain amplification even at low levels of pain. Commenting on the research, Prof. Sandkühler said: "We were able to show in a controlled laboratory system that the amplification arises even when the pain is quite weak. We actually used electrical impulses that were 50 times weaker than those previously employed to induce this response. Weak pain signals like these are symptomatic of the healing of wounds and of inflammation."

Prof. Sandkühler's group was also able to identify the cells responsible for this previously unknown phenomenon. They are located in the lamina I of the spinal dorsal horn, and ensure that signals from peripheral pain fibres are transmitted to spinal nerve tracts leading to the brain.

Illuminating Evidence

As part of this large-scale project, Sandkühler and his team were also able to indicate which cellular mechanism is behind low-level pain enhancement. Cells were loaded with dyes which emit light when exposed to sufficient concentrations of calcium ions. This made it possible to show that the concentration of calcium ions in these lamina I cells also increases dramatically in response to weak pain impulses. This is one of a multitude of cases in which calcium ions are involved in cellular signal transmissions. Here, the calcium ions activate enzymes which amplify the pain impulses.

These new findings are of fundamental importance for pain therapy. As Sandkühler put it: "Treating patients with pain killers for a short period of time after an operation, for example, is not an effective means of avoiding pain enhancement. Pain therapy must be continued without interruption until the pain has largely subsided."

In order that these recommendations may be implemented quickly, Prof. Sandkühler is playing a part in organising an expert meeting on the topic. The "Risk Assessment in Pain Therapy" symposium will take place on 10th November 2006, with the aim of evaluating the opportunities and risks of current therapeutic procedures in the light of these new findings. In cooperation with IGOST (the Interdisciplinary Society for Orthopaedic Pain Therapy), Sandkühler has succeeded in attracting representatives of DGSS (the German Society for the Study of Pain), ÖSG (the Austrian Pain Society) and internationally renowned pain researchers to this event in Vienna. This should mean that the findings of this FWF project can soon feed through into specific recommendations for clinical therapy.

Till C. Jelitto | alfa
Further information:
http://www.fwf.ac.at/en/public_relations/press/pv200608-en.html
http://www.prd.at

More articles from Health and Medicine:

nachricht Study suggests possible new target for treating and preventing Alzheimer's
02.12.2016 | Oregon Health & Science University

nachricht The first analysis of Ewing's sarcoma methyloma opens doors to new treatments
01.12.2016 | IDIBELL-Bellvitge Biomedical Research Institute

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

Im Focus: Molecules change shape when wet

Broadband rotational spectroscopy unravels structural reshaping of isolated molecules in the gas phase to accommodate water

In two recent publications in the Journal of Chemical Physics and in the Journal of Physical Chemistry Letters, researchers around Melanie Schnell from the Max...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

IHP presents the fastest silicon-based transistor in the world

05.12.2016 | Power and Electrical Engineering

InLight study: insights into chemical processes using light

05.12.2016 | Materials Sciences

High-precision magnetic field sensing

05.12.2016 | Power and Electrical Engineering

VideoLinks
B2B-VideoLinks
More VideoLinks >>>